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Abstract. Regulation of mRNA translation and stabil- 
ity plays an important role in the control of gene ex- 
pression during embryonic development. We have re- 
cently shown that the tissue-specific expression of the 
RAR[32 gene in mouse embryos is regulated at the 
translational level by short upstream open reading 
frames (uORFs) In the 5'-untranslated region (Zim- 
mer, A., A.M. Zimmer, and K. Reynolds. 1994. J. Cell 
Biol. 127:1111-1119). To gain insight into the molecular 
mechanism, we have performed a systematic muta- 
tional analysis of the uORFs. Two series of constructs 
were tested: in one series, each uORF was individually 
inactivated by introducing a point mutation in its start 
codon; in the second series, all but one ORF were inac- 
tivated. Our results indicate that individual uORFs may 
have different functions, uORF4 seems to inhibit trans- 
lation of the major ORF in heart and brain, while uORFs 
2 and 5 appear to be important for efficient translation 
in all tissues. To determine whether the polypeptide en- 
coded by uORF4 or the act of translating it, is the sig- 
nificant event, we introduced point mutations to create 
silent mutations or amino acid substitutions in uORF4. 
Our results indicate that the uORF4 amino acid coding 
sequence is important for the inhibitory effect on trans- 
lation of the downstream major 0RF. 
T 
hE scanning model for translational initiation pre- 
dicts that the translational initiation site is dictated 
by the location and sequence context of the initia- 
tion codon (Kozak, 1989a). The 40S preinitiation complex 
binds to the 5' cap-proximal region of the mRNA and mi- 
grates downstream until it encounters an AUG in a favor- 
able  context.  At  this  point,  the  60S  ribosomal  subunit 
binds  to the  complex and  protein synthesis commences. 
Most eukaryotic mRNAs have a short 5'-untranslated re- 
gion (UTR) 1 without stable secondary structures and no 
upstream AUGs. These features enable the preinitiation 
complex to efficiently scan the 5'-region for the translation 
start site. Complex 5'-UTRs with upstream AUGs and/or 
the ability to form stable secondary structures are found 
only in  a  small  minority of transcripts  (Kozak,  1989a). 
Strinkingly, most of these genes, which include homeobox 
genes,  proto-oncogenes, transcription  factors, and signal 
transduction components are thought to play an important 
role in the  regulation of embryonic development. It has 
been proposed that expression of many of these genes is 
regulated at the translational level (Kozak, 1989a). 
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The retinoic acid receptor-~2 (RARI32)  mRNA  has  a 
complex 5'-UTR. RAR[32 is a retinoic acid (RA)-depen- 
dent transcription factor that belongs to the superfamily of 
steroid/thyroid  hormone  receptors  (Evans,  1988).  RA 
plays an important role as a signaling molecule during em- 
bryoic development and homeostasis. It is a  very potent 
teratogen and can induce a large variety of severe congen- 
ital defects, depending on the dose and time of exposure. 
Administration during early gastrulation, for example, re- 
sults in craniofacial and heart defects (Kochhar, 1967)  as 
well  as  skeletal  abnormalities  (Kessel  and  Gruss,  1991; 
Kessel, 1992). 
The family of RAR  genes consists  of three  members 
designated as RARc~, RARI3, and RARe/. Several differ- 
ent  transcripts  are  generated  by  each  of  these  genes 
through  differential  splicing  and  promoter  usage.  The 
transcripts  have different 5'-UTRs  and  encode for pro- 
teins with distinct NH2 termini. All isoforms share a com- 
mon DNA-binding and COOH-terminal domain. Expres- 
sion of the RARI32 isoform is strongly induced upon RA 
treatment through an RA responsive element. The expres- 
sion  pattern  in gastrulating embryos is  consistent with  a 
potential  role  in  teratogenesis  (Zimmer  and  Zimmer, 
1992). 
We  have  previously  shown  that  expression  of  the 
RARI32 mRNA is regulated by a translational mechanism. 
The 5'-UTR of the RAR[32 mRNA, but not of the other 
isoforms,  contains  five  short  upstream  open  reading 
frames (uORFs) which precede the major ORF (Reynolds 
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uORFs encode small peptides of 16-21 amino acids. Three 
of these five uORFs have staggered organization in which 
the stop codon of one uORF overlaps with the start codon 
of the following uORF. We studied the role of the 5'-UTR 
in  the  regulation  of  the  RAR[32  gene  by  fusing  the 
RAR[32 5'-region including the RAR[32 promoter, the 5'- 
UTR, and the first 29 codons of the major open reading 
frame, to the coding region of the bacterial [3-galactosidase 
gene (lacZ). Expression of the lacZ gene in these RARI32- 
lacZ reporter constructs was subject to regulatory mecha- 
nisms  mediated  by  the  5'-UTR  (Reynolds  et  al.,  1991; 
Zimmer and Zimmer, 1992). LacZ expression was surpris- 
ingly efficient in transgenic embryos, considering the ob- 
stacles that the uORFs are thought to create for scanning 
ribosomes. Strikingly, mutations in the overlapping start/ 
stop codons or deletion of all uORFs led to deregulated 
translation  of RAR[32-1acZ  reporter constructs  in  heart 
and  brain,  suggesting  that  the  uORFs  control  RAR[32 
translation  in  a  tissue-specific  manner  (Zimmer  et  al., 
1994). 
To gain insight into the molecular mechanism underly- 
ing the  translational  regulation, we  have now examined 
the  role  of individual  uORFs.  Two  series  of constructs 
were generated.  One series contained mutations  in only 
one uORF, and in the other series, all except one uORF 
were mutated. Analysis of the lacZ expression pattern in 
transgenic  embryos  derived  with  these  constructs  indi- 
cated that the 5'-UTR is composed of inhibitory and stim- 
ulatory uORFs,  uORF4,  in  particular,  appeared  to play 
the most important role for the inhibition of translation in 
heart and brain. We present evidence that the peptide en- 
coded by uORF4 may be responsible for the inhibition of 
translation  of the  downstream major ORF in  heart  and 
brain tissues. 
Materials and Methods 
M1 to M5 Constructs 
Individual uORFs in the RARI32-5'LUTR  were inactivated by introducing 
point mutations into the start codons using an oligonucleotide-directed 
mutagenesis system (Amersham Corp., Arlington Heights, IL) according 
to the manufacturer's recommendations. The template was a  PstI frag- 
ment from the wild-type reporter construct RLZ79 (Reynolds et al., 1991) 
that was inserted into M13mp18. 
The following oligonucleotides were used for site-directed  mutagenesis: 
M1-GTCCT  CTGCA  ACCCA  GTCTI';  M2-TCATr  TACCA  ATTIC 
GAGGC;  M3-CCAAA  TGATC  AATFA  CCATT;  M4-CCCGA  AT- 
CAA GAATT ATGAC; M5-ACGAA CTCCT TCAAA CTCTC.  The 
mutated PstI fragment was reinserted into RLZ79 after partial PstI diges- 
tion. All mutations were verified  by di-deoxy sequencing. 
MOI to M05 Constructs 
Constructs were made that had all but one of the uORFs inactivated by 
point  mutations.  HindIII-BamHI fragments that  contained  the  entire 
RARI32-5'-UTR from M2,  M3,  M4,  M5,  and M0  (Zimmer et al.,  1994) 
were subcloned into Bluscript KS+. The resulting plasmids were named 
RM2, RM3, RM4, RM5, and RM0, respectively. 
RM01:  Mutations in  the uORF4 and uORF5 start sites in constructs 
RM4 and RM5 were combined into one construct using a unique BsaAl 
site  between uORF4 and uORF5 (Zimmer et al.,  1994) to yield  plasmid 
RM4+5.  The HindIII-BamHI fragment was subsequently inserted into 
M13mp18 and start codons of uORF2 and uORF3 were mutated using the 
oligonucleotide:  CATCA ATTAC CAATT TCCAGG. 
RM02,  RM03, and RM04: To obtain these plasmids we took advantage 
of an AluI site between uORF3 and uORF4. A  141-bp  PpuMI x  AluI 
fragment contained the start codons of uORF2 and uORF3, and a 268-bp 
AluI x  BamHI fragment contained the start sites of uORF4 and uORFS. 
RM02 was made by inserting a PpuMI ×  AluI fragment from RM3 and a 
AluI  ×  BamHI fragment  from RM0  into  RM0  cut  with  PpuMI  and 
BamHI. RM03 contained the PpuMI x  AluI fragment from RM2 and the 
AluI ×  BamHI fragment from RM0,  and RM04 the PpuMI x  AluI frag- 
ment from RM0 and the AluI × BamHI fragment from RM5. 
RM05:  A  BsaAI fragment that covers the  uORF5 start codon from 
RM0 was replaced by the corresponding fragment from RM5. All uORFs, 
except  uORFS, were deleted  in  the  resulting plasmid  RM05.  All  con- 
structs were verified  by sequencing. 
The final  MOX constructs were obtained by inserting a  BamHI frag- 
ment from RLZ79 containing the lacZ gene into the BamHI site  of the 
RMOX plasmids. 
M4* M04*, and M3* Constructs 
Three constructs were made to test the effects  of mutations in the amino 
acid sequence of uORF3 and uORF4. 
M4*  and M04*  constructs were derived from RLZ79  and  RMO, re- 
spectively,  by introducing point mutations into the first or second bases of 
codons 5, 6, 12, and 13 of the uORF4 inferred peptide. The oligonucleo- 
tide used to obtain M4* was as follows:  GCC CTT l'll  TrG GCT CCT 
TGG CTG TI'G GTC TIT TIT CCC GCC CCG. The oligonucleotide  used 
to obtain M04* was similar,  but with the addition of bases to reintroduce 
the ATG into its original context and was as follows: CCC TIT TIT GGC 
TCC TTG GCT GTT GGT CTT TIT TCC CGC CCC GAA TCA TG. 
M3* was derived from RLZ79 by introducing point mutations that did 
not alter the uORF4 amino acid  sequence. The oligonucleotide used to 
obtain M3* was as follows: CGG CCT "ITI" TTG ACA GGT AGG CTG 
TTG GTC TTT CTC CCA CCC CCG AATC. 
Generation and Analysis of Transgenic Mice 
Transgenic mouse lines  and  transgenic embryos were  established  and 
stained for 13-galactosidase (i3-gal) activity  as previously described (Rey- 
nolds et al., 1991; Eisel et al., 1993). 
13-Gal activity  was determined by enzymatic assays in extracts made 
from E 12.5 embryos and adult tissues.  Embryos were dissected free from 
extraembryonic tissues and stored at -80°C. DNA was isolated from the 
extraembryonic material and analyzed by PCR to identify  transgenic em- 
bryos. Adult organs were dissected,  divided  into equal halves,  and stored 
at  -80°C. Frozen tissues were homogenized in 500  pxl PM2  buffer (100 
mM Na-phosphate, 2 mM MgSO4, 0.1 mM MnCI2, 0.5%  [vol/vol] [3-mer- 
captoethanol, pH 8.0). Cell debris was pelleted by centrifngation in a mi- 
crocentrifuge. 13-Gal activity was measured at 570 nm in a 96-well microti- 
ter plate after adding 25 Ixl chlorophenolred-[3-o-galactopyranoside  to 100 
txl embryo extract.  At least three embryos or tissue extracts were analyzed 
from each transgenic line. 
RNA was isolated using RNA Stat-60 (Tel-Test "B" Inc., Friendswood, 
TX) according to the manufacturer's recommendations. RNA from em- 
bryos was analyzed by RNase protection assays.  RNA from adult tissues 
was analyzed by Northern blotting. 
To obtain a template for in vitro translation, a Bsu361 ×  EcoRI frag- 
ment that contained most of the lacZ gene was deleted from RLZ79.  A ra- 
diolabeled RNA probe was made by in vitro translation of this plasmid 
with SP6 polymerase in the presence of 32P-a-GTP,  after digestion with 
BsaAI. 
The endogenous RARI32 mRNA protects a 187-nt fragment, while the 
transgene protects a 423-nt  fragment. 10 Izg of total RNA from embryos 
were hybridized with 1.5  x  105 cpm of this probe in hybridization buffer 
(40 mM Pipes,  pH 6.4; 1 mM EDTA; 0.4 M NaC1; 80%  [vol/vol] forma- 
mide) at 50°C overnight. 350 txl ice-cold  RNase digestion buffer (10 mM 
Tris, pH 7.5; 5 mM EDTA; 300 mM NaC1) and 4 tzl RNase stock (200 
Ixg/ml RNase T1; 4 mg/ml RNase A; 10 mM Tris, pH 7.5; 15 mM NaCI) 
was added to this mixture and incubated at 37°C for 60 min. Subsequently, 
20 Ixl of 10% SDS and 10 Ixl proteinase K (10 mg/ml) were added and in- 
cubated for an additional 15 min. The mixture was extracted with 400 pA 
phenol/chloroform/isoamylalcohol (25:24:1) and the protected RNA was 
precipitated with ethanol after adding 1 ~1 tRNA (25 mg/ml) as a carrier. 
The  pellet  was dissolved  in  loading  buffer  (80%  formamide:  10  mM 
EDTA; 1 mg/ml xylene cyanol FF; 1 mg/ml bromophenol blue) and sepa- 
rated  on  a  6%  sequencing gel.  Radiolabeled  Bluescript SK+  DNA di- 
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dried and analyzed using a Bio-lmaging Analyzer (Fuji Medical Systems 
Inc., Stanford, CT). 
Total  RNA from adult tissues (10  Ixg) was separated electrophoreti- 
cally on a formaldehyde gel, blotted onto Nytran (S&S) membrane, and 
hybridized to a radiolabeled RNA probe. The blot was washed 3 x  in 1 x 
SSPE/1% SDS at 65°C and 1 x  in 0.1  x  SSPE/I% SDS at 60°C and ana- 
lyzed using a Bio-Imaging Analyzer. 
RNA  expression levels were quantitated  using the N1H  Image Pro- 
gram. The endogenous RARI32 RNA or 28S RNA served as an endoge- 
nous standard in RNase protection assays or Northern blots, respectively. 
Translational efficiency was estimated by determining the ratio of p-gal 
activity (average of four samples) to RNA expression levels. 
Results 
Deletion of Single uORFs: Enhanced or Reduced 
Expression Levels 
We have previously shown that expression of the RARp2 
gene in heart and brain tissues is regulated during embry- 
onic development at the translational level by five uORFs 
in the 5'-UTR (Zimmer et al., 1994).  To analyze the role 
of individual uORFs, we generated a series of constructs 
Figure 1.  Schematic representation of the RARp2-5'-UTR  in the 
wild-type (RLZ79)  and mutant constructs. In the M1-M5 series 
of constructs, one uORF  was inactivated by introducing a  point 
mutation  into  the  start  codon.  (M1-M4)  AUG  is  changed  to 
UUG; (M5) AUG  was changed to AAG.  In the M01 to M05 se- 
ries, all uORFs except one were mutated. Constructs M4*, M3*, 
and  M04*  contained  mutations  that  altered  the  amino  acid se- 
quence of the uORF3  and/or uORF4  encoded peptides. See text 
for details. 
with  point  mutations  in  one  of the  uORF  start  codons. 
These mutations were designed to delete one of the uORFs 
while leaving the others intact (Fig. 1, M1 to M5; uORF1 is 
mutated in M1, uORF2 in M2, etc). With this series of con- 
structs, we asked whether the deletion of only one uORF 
would be sufficient to alter expression in heart and brain. 
Several transgenic mouse lines and transgenic founder em- 
bryos were  generated  with  these  constructs.  To  analyze 
the  lacZ  expression  pattern,  embryos were  isolated  be- 
tween embryonic days E  9.5 and E  12.5, fixed, and stained 
for p-gal activity (Fig. 2 and Table I). 
[3-Gal staining in these embryos was compared to that of 
embryos generated  with  the  wild-type  RLZ79  construct 
(Reynolds et al.,  1991;  Zimmer and  Zimmer, 1992;  Zim- 
mer et al., 1994). E  12.5 embryos from each construct were 
sectioned to evaluate the p-gal staining in internal organs. 
We  found  that  transgenic  animals carrying the  M1  con- 
struct expressed lacZ in the same pattern as mice with the 
wild-type RLZ79 construct. In particular, there was no de- 
tectable p-gal staining in the hearts and brains of TG-M1 
embryos (Fig. 2 A, Table I). This indicates that the dele- 
tion of uORF1 does not affect the translation of the down- 
stream major ORF within the limits of detection.  Hence, 
we  have  used  the  p-gal staining  pattern  of TG-M1  em- 
bryos as a reference for comparison of other mutant con- 
structs. 
Interestingly,  TG-M4  embryos  expressed  lacZ  in  the 
heart  and brain, while TG-M1, TG-M2, TG-M3, and TG- 
M5 embryos did not express lacZ in these tissues (Fig. 2). 
At E 9.5, TG-M4 showed 13-gal staining in the brain. E  10.5 
and older embryos also expressed lacZ in the heart, p-Gal 
staining in other tissues of TG-M4 embryos was indistin- 
guishable from TG-M1  orTG-RLZ79 embryos. These re- 
sults indicate that the deletion of uORF4 leads to transla- 
tion of the RAR[32 mRNA in heart and brain and points 
to an important role for uORF4 in the inhibition of trans- 
lation in these tissues. 
Strikingly,  the  mutation  of either  uORF2,  uORF3,  or 
uORF5 in constructs M2, M3, or M5, respectively, seemed 
to reduce lacZ expression levels (Fig. 2). We consistently 
found relatively weak p-gal staining in all embryos gener- 
ated from these constructs, particularly in the thoracic re- 
gion of the spinal cord at E  12.5. This was never seen with 
the wild-type RLZ79, M1, or M4 constructs.  Histological 
sections  of  TG-M2  and  TG-M5  embryos  revealed  that 
lacZ staining in other tissues, i.e., head mesenchyme, tra- 
chea,  oesophagus,  umbilical  cord,  and  genital  eminence, 
was  very weak  or  not  detectable.  TG-M2  embryos also 
failed to express in nerve sheets (Fig. 2 B). At E  9.5, lacZ 
staining was weaker in the most rostral and caudal regions 
of TG-M5 embryos and very weak in TG-M2 embryos. 
To get a  better estimate of the  amount of protein syn- 
thesized, we quantitated RARp21acZ mRNA and protein 
levels in E  12.5  embryos. We found that mRNA levels in 
M2  and  M5  embryos  were  12.5%  and  45%  of  that  of 
RLZ79  embryos,  respectively.  However,  protein  levels 
were only -3%  and 5%  of the RLZ79 embryos (Fig. 3), 
indicating a very inefficient translation of these constructs. 
Translation  of M1  and  M4  were  also  about  25%  lower 
than RLZ79. These results suggest that the precise organi- 
zation of uORFs is important to ensure efficient transla- 
tion of the major ORF. 
Reynolds et al. Tissue-specific Translational Regulation  829 Figure 2.  Comparison of lacZ expression patterns of constructs with a mutation in a single uORF. A schematic representation of the 5'- 
UTR of the mutant constructs is given at the bottom. M1 had a mutation in the AUG of uORF1, M2 in uORF2, etc. The major ORF is 
indicated by a blue box. Embryos were removed and stained for [3-gal activity under identical conditions. Whole mount staining of E 9.5 
embryos from  each construct is shown in the upper panel; E  12.5 embryos are shown  in the middle panel; and transverse sections 
through the hearts of E  12.5 embryos are shown in the lower panel. At E 9.5 most constructs expressed lacZ at similar levels except M2 
which expressed only in the lateral mesenchyme (small arrows). At E  12.5 [3-gal staining was consistently weaker in M2 and M5 em- 
bryos. The large arrow indicates 13-gal  staining in the telencephalon of M4 embryos. Note the [3-gal staining in the heart wall and papil- 
lary muscles of M4 mice. 
We also determined  translational efficiency of the mu- 
tant constructs in hearts and brains from adult animals. [3-Gal 
enzymatic activity in these tissues was very low in TG-M1, 
TG-M2,  TG-M5,  and  TG-RLZ79  animals,  but  TG-M4 
mice exhibited significant activity. Comparison of protein 
and  mRNA  levels  revealed  that  the  translational  effi- 
ciency of M4-RNA was 7  (brain)-12 (heart) times higher 
than RLZ79-RNA (Fig. 3). 
Constructs with Single uORFs: Inhibitory and 
Stimulatory uORFs 
The  above results suggest that  uORF4  is involved in the 
inhibition of translation of the downstream RAR[32-AUG 
in  heart  and  brain, while other uORFs  seemed  to be re- 
quired for efficient translation. To determine the effect of 
a  single uORF  on lacZ expression, we generated a  series 
of constructs  in  which  all  but  one  uORF  were  mutated 
(Fig.  1; constructs M01  to M05;  uORF1  is intact in  M0I, 
uORF2 in M02, etc.). With this series we asked whether a 
single uORF  would be  sufficient to  inhibit expression in 
heart  and  brain.  Transgenic  lines  were  established  with 
M01  only. The  other constructs were  analyzed in  several 
independently  derived  transgenic  founder  embryos  (see 
Table I). 
TG-M04 and TG-M03 embryos did not express lacZ at 
any  developmental stage  in  heart  or  brain  (Fig. 4),  thus 
supporting  the  inhibitory  role  of  uORF4  on  brain  and 
heart expression of lacZ. It was somewhat surprising that 
uORF3 as a solitary uORF also abolished heart and brain 
expression  in  TG-M03  embryos,  because  its  deletion  in 
construct M3 had no effect. It is possible that uORF3  is a 
weaker repressor of translation or it may be related to the 
fact that uORF3 is the longest of all uORFs. 
Interestingly, TG-M01, TG-M02, and TG-M05 embryos 
expressed lacZ at different levels in heart and brain. In the 
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9.5  10.5  11.5  12.5 
TG  F0 
Construct  lines  embryos  H  B  H  B  H  B  H  B 
RLZ79  2  22  ....  a 
M1  4  0  ..... 
M2  1  4  ..... 
M3  0  9  -  -  nd  nd  nd  nd  -  - 
M4  5  16  -  ++  +  ++  +  ++  ++  + 
M5  2  6  ..... 
M01  3  0  ++  +  ++  +  +  -  +  - 
M02  0  4  +  +  nd  nd  nd  nd  +  - 
M03  0  7  -  -  nd  nd  nd  nd  -  - 
M04  0  6  -  -  nd  nd  nd  nd  -  - 
M05  0  8  -  +  nd  nd  nd  nd  +  ++ 
M4*  0  16  -  ++  nd  nd  nd  nd  ++  b 
M3*  0  10  -  -  nd  nd  nd  nd  -  c 
M04*  0  15  -  +  nd  nd  nd  nd  +  + 
Summary of the expression of constructs  in the heart (H) or the brain (B) of transgenic 
embryos.  Several transgenic lines (TG lines) or transgenic founder embryos (F0 em- 
bryos) were analyzed for each construct. 
-, no expression; +, weak expression: + +, strong expression; nd, not done; a, only 
one line expressed in the telencephalon (Zimmer et al.,  1994): b =  one out of twelve 
embryos expressed in the brain: c, one embryo expressed in all regions of the brain. 
brain, all embryos expressed a relatively low level at E 9.5, 
although  13-gal staining  in  TG-M05  embryos was  some- 
what stronger than in TG-M01 or TG-M02 embryos. At E 
12.5,  only  TG-M05  embryos  expressed  strongly  in  the 
brain. We compared the amount of [3-gal staining in E  12.5 
embryos generated with M0 (Zimmer et al.,  1994) or M05 
and  found  much  stronger  staining  in  TG-M05  embryos 
(data not shown).  Hence, it appears  that uORF5  stimu- 
lates translation in the brain. 
In the heart, TG-M01 exhibited more 13-gal staining at 
E  9.5 when compared with other embryos of this series or 
with TG-M0 embryos, thus suggesting a  stimulatory role 
for uORF1. At E  12.5, TG-M01, TG-M02, TG-M05, and 
TG-M0 expressed at similar levels. 
uORF4 Encodes an Inhibitory Peptide 
To determine if the inhibitory effect of uORF4 is depen- 
dent on its amino acid coding sequence, we have changed 
the amino acid sequence by introducing point mutations 
into the  first or second bases  of codons 5, 6,  12,  and  13 
(Fig. 5 A). Because uORF3 and uORF4 overlap, these mu- 
tations  also  changed  the  amino  acid  sequence  of  the 
uORF3 encoded peptide. The resulting plasmid was called 
M4*. Another construct, M3*, contained point mutations 
in nucleotides adjacent to those that were altered in M4* 
(Fig. 5 B). These mutations, however, preserved the amino 
acid  sequence  of  the  peptide  encoded  by  uORF4  but 
changed the uORF3 peptide. The general organization of 
uORFs in these constructs was not changed. 
Four E  9.5  and  twelve E  12.5  transgenic  founder em- 
bryos were derived with this construct and stained for [3-gal 
expression. Representative embryos are shown in Fig. 5 A. 
At E  9.5, all TG-M4* embryos expressed in the brain, but 
not in the heart. At E  12.5, eight out of twelve TG-M4* 
Figure  3.  Determination  of 
RAR[~2-1acZ mRNA  and pro- 
tein levels. (A)  RNA  from  E 
12.5 embryos was analyzed by 
ribonuclease  protection  as- 
says. The  top bands represent 
the  transgenic transcripts  and 
the lower bands, the endoge- 
nous RAR[32 mRNAs.  Com- 
parison  of  the  endogenous 
RARI32 expression levels with 
the transgene mRNA  showed 
that  expression  levels varied 
between  two  and  eightfold 
between  individual lines.  (B) 
Northern blot analysis of heart 
and  brain  tissues  from  adult 
animals. The top panel shows 
the autoradiograph. The lower 
panel  shows  the  ethidium 
bromside-stained  RNA  gel. 
(C)  Quantitation  of  RARI32- 
lacZ RNA  and protein levels. 
Protein levels were determined 
enzymatically  (see  Materials 
and  Methods).  Translational 
efficiency is  expressed  in  ar- 
bitrary  values as  the  ratio of 
protein activity to RNA  level. 
Averages  and  standard  errors 
were  compiled  from  at  least 
three  independent  [3-gal  as- 
says. Note that brain tissues ex- 
hibited significantly more [3-gal 
activity than heart tissues. 
Reynolds et al. Tissue-specific  Translational  Regulation  831 Figure 4.  Comparison of lacZ expression patterns of constructs with solitary uORFs. The bottom panel shows a schematic representa- 
tion of the 5'-UTR of the constructs used in this experimental series. In M01, all uORFs were mutated except uORF1, in M02 all except 
uORF2, etc. Whole mount staining of E 9.5 embryos is shown in the upper panel and E 12.5 embryos, in the middle panel. Transverse 
sections through the hearts of E 12.5 embryos are shown in the lower panel. Note 13-gal staining in the heart of TG-M01 embryos at E 9.5 
(asterisk) and in the telecephalon of TG-M05 embryos (arrowheads). TG-M01 and TG-M05 embryos expressed in more cells of the 
heart wall compared to embryos generated with M0, a construct that lacks all uORFs (Zimmer et al., 1994). No expression was seen in 
papillary muscle (compare to M4, Fig. 5). LacZ expression in TG-M02 embryos was similar  to that of TG-M0 embryos. TG-M03 and 
TG-M04 embryos did not express in the heart. 
embryos expressed in the heart, but only one expressed in 
the  brain.  Thus,  the  altered  regulation  of translation  ob- 
served  with M4* is very similar  to that  seen with  M4.  In 
contrast,  13-gal activity in TG-M3*  embryos was identical 
to that of wild-type TG-RLZ79 embryos (Fig. 5 B). 
Finally, we wanted  to determine  if the  altered  uORF4 
coding sequence (in M4*) could inhibit expression in heart 
and brain when introduced  as  a  solitary uORF in the 5'- 
UTR,  as  the  wild-type  sequence  did  (in  construct  M04). 
The corresponding mutant construct M04* is shown in Fig. 
5 C. A  total of nine E  9.5 and six E  12.5 embryos were ana- 
lyzed. As shown in Fig. 5 C, the mutated uORF4 sequence 
failed to inhibit expression in heart and brain. 
Discussion 
There  is  accumulating  evidence  that  retinoid-dependent 
pathways play a crucial role in the regulation of brain and 
heart  development  and  myocardial  differentiation  (Hart 
et al., 1992; Wiens et al.,  1992; Kastner et al.,  1994; Men- 
delsohn  et  al.,  1994; Moklentin  et  al.,  1994; Sucov et  al., 
1994; Yutzey et  al.,  1994; Dyson et  al.,  1995; Twal  et  al., 
1995; Wu et al., 1995; Zhou et al., 1995). It is likely that the 
precise coordination of expression of the mediators of ret- 
inoid-signaling, the retinoic acid receptors, is essential. We 
have  recently  shown  that  expression  of  the  RARI32 
mRNA in heart and brain is specifically regulated  during 
embryonic development  and in adult  animals  at the level 
of translation (Zimmer et al., 1994). The translational con- 
trol involves small uORFs in the 5'-UTR. In this study we 
looked at the function of each of the uORFs. Our results 
indicate that the uORFs have distinct functions (Fig. 6). 
The mutation of either uORF2,  ORF4, or uORF5 start 
codon leads  to an altered  regulation of expression  of the 
major ORF. One of the most striking effects was a  mark- 
edly  reduced  translational  efficiency of the  downstream 
RAR[32-AUG  after  mutating  uORF2  or  uORF5,  which 
was particularly  evident  in  the  thoracic  region  of E  12.5 
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uORF4 amino acid sequence. 
The amino acid sequence of 
uORF4  was  altered  in  con- 
struct  M4*  by  introducing 
point mutations into the first 
or second bases of codons 5, 
6,  12,  and  13.  These  muta- 
tions also altered the  amino 
acid sequence of the uORF3 
encoded peptide, but did not 
change the overall organiza- 
tion  of  uORFs.  Transgenic 
embryos were isolated on E 
9.5  (top  panel)  or  E  12.5 
(middle  panel)  and  stained 
for [3-gal activity. Note  lacZ 
expression in the brain at E 
9.5 and heart at E 12.5 (lower 
panel).  (B) Point  mutations 
that  altered  the  nucleotide 
sequence  in  the  uORF4  re- 
gion and the amino acid se- 
quence  of  the  uORF3  en- 
coded  peptide,  but  not  the 
uORF4  encoded  peptide. 
The  mutated  nucleotides 
were  in  neighboring  posi- 
tions  of  those  changed  in 
M4*. LacZ expression in TG- 
M3*  embryos  was  identical 
to wild-type TG-RLZ79 em- 
bryos and not found in hearts 
and brains. (C)  the mutated 
uORF4  as a  solitary uORF. 
The M04* construct was sim- 
ilar to the M04 construct, but 
contained  mutations  in  the 
amino  acid  sequence  of 
uORF4.  Note  that  the  mu- 
tated uORF4 sequence did not 
inhibit  expression  in  heart 
and  brain,  as  did  the  wild- 
type sequence. 
embryos. These results indicate that both uORFs are im- 
portant for efficient expression of the major ORF in all tis- 
sues. We also found relatively low mRNA levels in TG-M2 
and  TG-M5  mice.  This  could  be  due  to  transcriptional 
variation, which is commonly observed between individual 
transgenic  lines,  or  it  may  be  related  to  the  fact  that 
mRNA  stability is often  correlated with  translation  (At- 
water et al., t990). Although mutating the AUG or uORF1 
had no apparent effect on the expression pattern of the re- 
porter gene construct, uORF1  seemed to enhance transla- 
tion in the heart when present as a  solitary uORF. These 
findings suggest that all of the uORFs in the RARi32-5'- 
UTR  inhibit  or  enhance  translation  of  the  downstream 
major ORF  in  heart and/or brain tissues. It appears that 
the complex arrangement  of uORFs  is important to pre- 
vent  translation in  heart  and  brain, while permitting ex- 
pression in other tissues. 
Is it possible that some of the  general translational ef- 
fects observed with constructs M2  and M5, or the tissue- 
specific effects seen with constructs M4 and M4*, or M24 
and M45  (Zimmer et  al., 1994),  are due to alterations in 
mRNA  secondary structure of the mutant transcripts? To 
explore this possibility we have analyzed the mRNA  sec- 
ondary structure  of the  human  and mouse  5'-UTRs  and 
those  of the  mutant  constructs  by the  method  of Zuker 
(1989).  This  analysis  revealed  that  the  RNA  secondary 
structure of mouse and human 5'-UTRs is very different, 
despite the fact that the sequence, in particular the region 
spanning uORF2 to uORF5, is highly conserved (Zimmer 
et al., 1994). The 5'-UTRs from both species are predicted 
to form unrelated stem-loop structures and have different 
free energies (nt 1-592; human, -186.3 kcal; mouse, -205.0 
kcal/mol).  Furthermore,  potential  alterations  in  mRNA 
secondary structure of the mutant constructs could not be 
reconciled with their expression pattern. 
Is it possible that a  minor form of mRNA  is generated 
through  tissue-specific splicing and promoter usage  from 
some mutant constructs tested in this study, and could this 
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possibly stimulates 
heart expression 
uORF3 
function unclear 
may be important 
for efficient translation 
uORF4  expression in brain 
encoded pepticle 
inhibits expression in 
heart and brain 
Figure 6.  Summary of the functional analysis of uORFs. 
minor form be the major functional mRNA? It is conceiv- 
able that the 13-gal assay is sensitive enough to detect such 
a minor mRNA form. We cannot address this question di- 
rectly in transgenic embryos, due to the limited availability 
and heterogeneity of cell populations in embryonic brain 
and heart tissues. However, we have now identified a tis- 
sue culture system, in which we can reproduce the differ- 
ential translation that we find in vivo (Reynolds, K., A.M. 
Zimmer, unpubished  results). This system will help us to 
address these and other questions in future experiments. 
While  we  cannot  exclude  the  possibility  that  subtle 
changes in RNA secondary structure, or the production of 
minority transcripts, contribute to the translational regula- 
tion, we feet that, in summary, our results provide over- 
whelming evidence that the organization and sequence of 
uORFs is most critical for translational  regulation of the 
RAR[32 mRNA. 
The AUG of uORF2 is in the best sequence context of 
all  uORFs  (UGGAAAAUGG).  It  is  the  only  one  that 
contains  the  preferred bases in  the  critical  positions  -3 
(A) and +4 (G). The AUG of uORF1, on the other hand, 
is  in  a  relatively  poor  sequence  context  (ACUGG- 
GAUGC). Therefore, the AUG of uORF2 is the most 5'- 
proximal AUG with a good sequence context and should 
be translated  efficiently according to the scanning model 
for translational  initiation.  Indeed  our results  show  that 
the deletion of uORF2 in the context of the wild-type 5'- 
UTR results in very low [3-gal activities indicating an im- 
portant function for uORF2. However, uORF2 is not re- 
quired when the other uORFs are mutated as in construct 
M0  (Zimmer et  al.,  1994),  or in  the  M0x  series  of con- 
structs (Fig. 4). These findings suggest that uORF2 is im- 
portant to alleviate the inhibitory effects ofrother uORFs. 
If one assumes that uORF2  is translated,  it is somewhat 
surprising that uORF4, the start codon of ~vhich overlaps 
the uORF2 stop codon, has such a strong inhibitory effect 
on translation in heart and brain. In eukaryotic cells, the 
reinitiation frequency increases with the distance between 
the 5'- and 3'-cistrons (Kozak, 1991a) which might suggest 
that initiation  at uORF4  should  be meager after transla- 
tion of uORF2.  However, reinitiation is very efficient in 
bacteria when the 5' and 3' ORFs overlap. 
The molecular basis for the positive effects of uORF1 
and uORF5  remains to be determined, but it may be re- 
lated to the fact that the RAR[32-5'-UTR can form corn- 
plex secondary structures (Zelent et al., 1991).  Stable sec- 
ondary  structures  (-50  or  -60  kcal/mol)  constitute  a 
strong barrier for scanning 40S ribosomal subunits (Pelle- 
tier and  Sonenberg,  1985;  Kozak, 1986),  while  80S  ribo- 
somes  can  penetrate  these  structures  to  some  extent 
(Kozak, 1989b). It has therefore been proposed that trans- 
lation of uORFs by 80S ribosomes might alleviate the in- 
hibitory effect (Kozak, 1991b). 
uORF4  was important for inhibiting  the translation  of 
the major RARI32-ORF. Mutation of uORF4 resulted in 
much more efficient lacZ expression in heart and brain tis- 
sues, but had little or no effect on other tissues (Figs. 2 D 
and 3 C). The presence of uORF4 as a solitary uORF was 
sufficient to block the expression of the reporter gene in 
hearts and brains, uORFs in the 5'-UTR as translational 
inhibitors have been reported for other cellular and viral 
genes such as TGF-133 (Arrick et al., 1991), GCN4 (Muel- 
ler and  Hinnebusch,  1986),  and  the  Rous  sarcoma virus 
(Donz6 and Spahr, 1992).  Several structural features have 
been determined  that  modulate  the  inhibitory effects of 
uORFs on translation downstream: (1) The sequence con- 
text of the upstream AUG (Kozak, 1984);  (2) the distance 
between the uORF termination site and the AUG of the 
major ORF (Peabody and Berg, 1986; Kozak, 1987; Miller 
and  Hinnebusch,  1989;  Grant  et  al.,  1994);  (3)  the  se- 
quence context of the uORF termination site (Miller and 
Hinnebusch,  1989);  (4)  the  length  of the  uORF  (Kozak, 
1987; Werner et al., 1987;  Abastado et al., 1991);  and (5) 
the sequence of the uORF encoded peptide (Geballe and 
Morris, 1994).  To explain the effects of uORFs on transla- 
tion  of the  major ORF,  it has been proposed that ribo- 
somes  (or  the  40S  subunit)  remain  associated  with  the 
mRNA after translating the uORF and reinitiate transla- 
tion at a downstream AUG. Hence, the act of translating 
the uORFs has been postulated to be critical in a regula- 
tory mechanism involving reinitiation while the sequence 
of the uORFs has little or no importance (Williams et al., 
1988). 
In contrast, our data suggest that the inhibitory effect of 
uORF4 on translation of the downstream major uORF de- 
pended  on the uORF4  coding sequence.  Changes  in  the 
nucleotide  sequence  which  preserve  the  uORF4  amino 
acid coding sequence  (in M3*) did not alter the lacZ ex- 
pression pattern, while changes in the uORF4 amino acid 
coding information  (in M4*)  or mutation of the  uORF4 
AUG (in M4) resulted in a similarly altered regulation of 
lacZ expression in hearts and brains. This finding indicates 
that the translation of uORF4 is not the significant event. 
Our data are most easily explained by the assumption that 
the peptide encoded by uORF4 has an inhibitory function. 
Interestingly, we have previously observed that extremely 
high levels of expression in the heart can be achieved by 
mutating the stop codon of uORF4  (construct M45; Zim- 
mer et al., 1994). Since uORF4 and the major ORF are in 
the same reading frame, this mutation may yield a larger 
fusion protein that initiates at the uORF4 AUG. It is con- 
ceivable that this fusion protein accounts for the high lev- 
els of lacZ activity in the hearts of TG-M45 embryos which 
would,  in  turn,  indicate  that  uORF4  is  efficiently trans- 
lated in the heart. Alternatively, the extension of uORF4 
might inactivate it and thus lead to a higher translation of 
the downstream major uORF. 
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the  S-Adenosylmethionine  Decarboxylase  (AdoMetDC) 
mRNA, the human cytomegolovirus gpUL48 mRNA, and 
the yeast  carbamoyl-phosphate  (CPA1)  mRNA  also  de- 
pend on the amino acid coding sequence of small uORFs 
in the 5'-leader sequence of those mRNA (Werner et al., 
1987; Schleiss et al., 1991; Hill and Morris, 1992; Degnin et al., 
1993; Hill and Morris, 1993). Mis-sense mutations in these 
uORFs, as well as their deletion, resulted in altered trans- 
lation of the downstream major ORF. The molecular basis 
of the translational regulation, however, remains to be de- 
termined. 
There is growing evidence that translation of mRNA is 
an important step in the regulation of many specific  eu- 
karyotic genes (Geballe  and Morris,  1994).  In particular, 
mRNAs  that  encode  for  retinoic  acid  receptors,  ho- 
meobox genes, proto-oncogenes, growth factors, and other 
proteins  with  an  important  role  in  embryonic  develop- 
ment, often contain small uORFs (Kessel and Gruss, 1988; 
Kozak,  1991b).  This  distinguishing feature  suggests  that 
translational regulation of gene  expression  may be com- 
mon among those genes. 
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